MINNEAPOLIS, September 27, 2021 / PRNewswire / – Imbio, a provider of artificial intelligence (AI) medical imaging for chronic pulmonary and cardiothoracic disease, and MEDICAL-NOTE, an application and software company for surgical management and communication multidisciplinary teams, announced their partnership to extend access to Imbio AI technologies through Italy. The partnership will provide valuable quantitative imaging data to surgeons, pulmonologists, radiologists and their patients directly through MEDICAL-NOTE applications.
Imbio technology provides personalized quantitative imaging analysis for patients with acute and chronic illnesses. Fully automated technology turns chest CT studies into rich visual maps of a patient’s lungs with accompanying reports that provide detailed data on the type and extent of abnormalities found in the images. Imbio algorithms support multiple clinical initiatives such as lung cancer screening, smoking cessation, surgical planning, and pulmonary embolism management programs, and can be used in clinical trials and academic research to many diseases.
“Imbio is delighted to embark on this adventure with MEDICAL-NOTE not only to expand our distribution, but also to integrate the outputs of our algorithms via their LUNG-NOTE application. Together, we can help clinicians use the vast quantitative information obtained from the diagnostic breast of patients. images for pulmonary pathologies to ultimately lead to concrete decision-making for better patient care, ”said Dave hannes, CEO of Imbio.
MEDICAL-NOTE simplifies the daily tasks of surgeons, optimizes preoperative planning and minimizes complications with digital solutions. LUNG-NOTE will initially feature Lung Density Analysis ™ (LDA) and Lung Texture Analysis ™ (LTA) from Imbio allowing clinicians to quickly visualize a patient’s lungs to support diagnostic decisions and of treatment for a variety of patient conditions, including COPD / emphysema and fibrotic disease.
“We are proud to announce this partnership with Imbio. Our mission to digitize the field of medicine has always been clear to us. By integrating both Imbio’s lung texture and lung density analysis products , we are now taking MEDICAL-NOTE to the next level, “mentioned Stefano Palma, Managing Director at MEDICAL-NOTE.
Teams from both companies will exhibit and present at the 37th National Congress of the Italian Society of Thoracic Surgery (SICT) in L’Aquila, Italy of September 30 to October 2.
MEDICAL-NOTE is an innovative startup that operates in the field of digital health and focuses on the development of software, mobile applications and hardware for medicine. MEDICAL-NOTE was born to stay close to surgeons when they have to make important choices, especially in terms of management, analysis and sharing of clinical information. With its digital solutions, MEDICAL-NOTE is revolutionizing the way surgeons access and use patient information before, during and after surgery. For more information, please visit www.medical-note.com.
Imbio is a leader in fully automated AI image analysis for acute and chronic lung and cardiothoracic conditions. Imbio’s solutions are transforming the way patients are discovered, diagnosed and treated, enabling physician productivity and more personalized care for patients. Imbio’s solutions are fully automated, approved by regulation and available from our global partners. For more information, please visit www.imbio.com.